KARIE BEASLEY: Open Payments
NPI 1134601214 · EVANSVILLE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,655 in 107 payments from 16 companies in 2025. Trend: 2023 $3,344 · 2024 $700 · 2025 $1,655
Food & beverage: $1,655
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 18 | $338 |
| ABBVIE INC. | 27 | $294 |
| Otsuka America Pharmaceutical, Inc. | 10 | $176 |
| Lundbeck LLC | 14 | $159 |
| Alkermes, Inc. | 11 | $155 |
| PFIZER INC. | 7 | $147 |
| Gilead Sciences, Inc. | 3 | $133 |
| Indivior Inc. | 3 | $64 |
| Vanda Pharmaceuticals Inc. | 2 | $40 |
| Corium, LLC | 2 | $36 |
Products named: CAPLYTA, REXULTI, VRAYLAR, ARISTADA, NURTEC ODT, ABILIFY ASIMTUFII, SUBLOCADE, QULIPTA.
Industry payments across IN — which companies pay providers there.
